REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
16/06/2025
Voltar para busca
Dado oficial do USPTO
ILITE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ILITE
ST13
US500000079243106Classe
1, 5, 9, 10, 42, 44
Pedido
79243106
Registro
6077015
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
17/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 42, 44
Data de depósito
05/06/2018
Data de registro
16/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2020
Última transação
17/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
SE
Examinador
RUTLAND, BARBARA
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SVAR Life Science AB
Representantes
Gregory J. Chinlund MARSHALL, GERSTEIN & BORUN LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Substances for use in cell-based reporter gene assaysassays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposesreagents for scientific and research use; reagents for chemical analyseschemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research usecell lines; components for cell-based analyses using optical methods and containing chemical reagentscells for scientific and research use
Classe 5
Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use
Classe 9
Laboratory apparatus in the nature of instruments for use in performing cell-based assays by means of optic detectionoptical quantification apparatus; computer software for use in optic based biological analysis; computer software for use in optic based biological analysis such as tools and methods used during drug developmentclinical diagnosisclinical monitoring or assay development
Classe 10
Medical diagnostic apparatus for use in testing assays
Classe 42
Cell-based assay servicescustom design and development of cell-based biochemical assays; cell-based assay servicescustom design and development of cell-based biochemical assays for use in drug developmentclinical diagnosisclinical monitoring or assay development; medical research; clinical research in the field of drug developmentclinical diagnosisclinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; conducting clinical trials for others; scientificmedical laboratory research and analysis services; scientific and medical laboratory testing services
Classe 44
Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes; medical servicestreating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/10/2020
FIMP
FINAL DISPOSITION PROCESSED
03/10/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/09/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
16/06/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/05/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/04/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/03/2020
PUBO
PUBLISHED FOR OPPOSITION
31/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
27/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/03/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/02/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
13/02/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/01/2020
CNSL
SUSPENSION LETTER WRITTEN
10/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2019
RFNT
REFUSAL PROCESSED BY IB
23/08/2019
CNRT
NON-FINAL ACTION MAILED
26/06/2019
CNRT
NON-FINAL ACTION WRITTEN
26/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2019
ALIE
ASSIGNED TO LIE
04/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/05/2019
RFNT
REFUSAL PROCESSED BY IB
29/03/2019
CNRT
NON-FINAL ACTION MAILED
18/01/2019
CNRT
NON-FINAL ACTION WRITTEN
16/01/2019
RFNT
REFUSAL PROCESSED BY IB
21/12/2018
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
13/12/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
30/11/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/11/2018
RFRR
REFUSAL PROCESSED BY MPU
13/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/10/2018
CNRT
NON-FINAL ACTION WRITTEN
26/10/2018
MAFR
APPLICATION FILING RECEIPT MAILED
23/10/2018
DOCK
ASSIGNED TO EXAMINER
19/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ILITE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.